January 28, 2015 9:25 AM ET


Company Overview of 4-Antibody AG

Company Overview

4-Antibody AG develops antibody therapeutics focused on immuno-oncology. Its technology platform Retrocyte Display is designed to generate therapeutic antibody drug candidates incorporating human antibody libraries expressed in mammalian B-lineage lymphocytes. The company also develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. The company was founded in 2002 and is based in Basel, Switzerland.As of February 12, 2014, 4-Antibody AG operates as a subsidiary of Agenus Inc.

Hochbergerstrasse 60C

Basel,  4057


Founded in 2002


41 61 633 22 60


41 61 633 22 61

Key Executives for 4-Antibody AG

Chief Executive Officer
Age: 67
Co-Founder and Chief Scientific Officer
Head of Research and Development - Germany
Chief Technology Officer
Age: 52
Head of Human Resources
Compensation as of Fiscal Year 2014.

4-Antibody AG Key Developments

4-Antibody AG Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-12-2013 02:15 PM

4-Antibody AG Presents at EBD Group's 7th Annual BIO-Europe Spring Conference 2013, Mar-12-2013 02:15 PM. Venue: Centre Covencions International Barcelona, Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain.

Similar Private Companies By Industry

Company Name Region
AnTeq AG Europe
ProteinGenesys AG Europe
MykoGreen Biotechnology AG Europe
BOWS Pharmaceuticals AG Europe
Epithelix SàRL Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 4-Antibody AG, please visit www.agenusbio.com/contact/4-antibody.php. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.